Nakashima Makoto, Watanabe Yusuke
Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Interv Cardiol. 2018 May;13(2):66-68. doi: 10.15420/icr.2017:28:1.
Transcatheter aortic valve implantation (TAVI) has become a standard treatment for severe aortic stenosis. Although this technique has reached relative maturity, further optimisation of patient selection and device implantation is essential to improve prognosis. Smaller body size is a predictor of a challenging TAVI procedure due to specific anatomical difficulty and adverse events including annulus rupture, acute coronary obstruction and vascular complications. A newer generation, lower profile TAVI system is useful for patients with smaller anatomy. Moreover, TAVI is superior to surgical aortic valve replacement in patients with a narrowing annulus because this treatement has a low incidence of prosthesis-patient mismatch.
经导管主动脉瓣植入术(TAVI)已成为重度主动脉瓣狭窄的标准治疗方法。尽管这项技术已相对成熟,但进一步优化患者选择和器械植入对于改善预后至关重要。体型较小是TAVI手术具有挑战性的一个预测因素,这是由于存在特定的解剖学困难以及包括瓣环破裂、急性冠状动脉阻塞和血管并发症在内的不良事件。新一代、外形更小的TAVI系统对于解剖结构较小的患者很有用。此外,在瓣环狭窄的患者中,TAVI优于外科主动脉瓣置换术,因为这种治疗方法发生人工瓣膜-患者不匹配的发生率较低。